Press Release: Toxys and Mutagentech Expand Access to Next-Generation Mutation Analysis Through Strategic Collaboration
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE New collaboration brings ultra-sensitive SMM-seq technology to pharmaceutical, chemical and consumer product developers, enabling deeper insight into genetic safety assessment. Oegstgeest, The Netherlands – August 26, 2026 –Toxys, a global leader in innovative toxicology testing, and Mutagentech, a biotechnology company specialized in advanced genomic technologies,...
Toxys and Institute for In Vitro Sciences Expand Partnership to Advance Adoption of New Approach Methodologies in Genetic Toxicology
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] Leiden, The Netherlands and Gaithersburg, MD, USA — 17 July 2026 — Toxys and the Institute for In Vitro Sciences (IIVS) are pleased to announce an expanded strategic partnership aimed at accelerating the adoption of innovative in vitro methods for chemical safety assessment. Under...
Press Release: OECD Publishes Test Guideline for ToxTracker®
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE New OECD guideline enables regulatory use of ToxTracker® for mechanistic genotoxicity assessment Oegstgeest, The Netherlands – 6 July 2026 – Toxys, a leading innovator in toxicology solutions, announces the publication of OECD Test Guideline 446A for ToxTracker, its flagship genotoxicity testing platform. ToxTracker is...
Press Release: Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
[vc_row][vc_column][vc_empty_space height="50px"][/vc_column][/vc_row][vc_row][vc_column width="2/3"][vc_column_text] PRESS RELEASE [/vc_column_text][/vc_column][vc_column width="1/6"][vc_single_image image="15778" img_size="full"][/vc_column][vc_column width="1/6"][vc_single_image image="15779" img_size="full"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing WILMINGTON, Mass. – October 8, 2025 – Charles River Laboratories International, Inc. (NYSE: CRL) and Toxys today announced a collaboration to...
Press Release: ToxTracker® Approved by OECD for Incorporation into Test Guideline Programme
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE ToxTracker® Approved by OECD for Incorporation into Test Guideline Programme Oegstgeest, The Netherlands. September 4th, 2025 - Toxys, a leading innovator in animal-free toxicology solutions, announces that its flagship product, ToxTracker®, has been accepted into the Organization for Economic Co-operation and Development (OECD) Test Guidelines Programme....
Press Release: Toxys launches MutaTracker
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE Toxys launches MutaTracker®, an all-in-one mammalian cell-based mutagenicity and genotoxicity assay Toxys announces the release of MutaTracker®, an innovative new approach method that integrates error-corrected sequencing into the ToxTracker® genotoxicity assay Oegstgeest, The Netherlands. September 3rd, 2024 – Mutagentech and Toxys have collaborated on creating...
ReproTracker 2.0: Pioneering Animal-Free Developmental Toxicity Testing with Enhanced Throughput and Efficiency
[vc_row][vc_column][vc_column_text]27th of August 2024 - Today, Toxys announces the higher throughput format of the ReproTracker assay for animal-free developmental toxicity predictions. ReproTracker 2.0 represents a novel advancement in the field of developmental toxicity testing that combines higher throughput, reduced compound requirement, and faster results, all...
Toxys publication on OECD ring trial validation of ToxTracker
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE Toxys reports positive results from the OECD ring trial validation of ToxTracker in a peer-reviewed article Oegstgeest, The Netherlands. April 9th, 2024 - Today Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©. ToxTracker is an in...
Toxys opens US office and production facility to accelerate growth
Oegstgeest, The Netherlands. March 16, 2022 - Toxys BV, a Dutch biotech company that offers a broad spectrum of innovative in vitro toxicology solutions for the safety assessment of novel medicines, (agro)chemicals, cosmetics, and food ingredients, today announces the opening of a sales office in...
Toxys appoints Scientific Advisory Board
Oegstgeest, The Netherlands. November 30, 2021 - Toxys BV is a biotech company based in Leiden, The Netherlands, that provides innovative, high-fidelity in vitro toxicity screening solutions to identify carcinogenic and other hazardous properties of compounds for the pharmaceutical, chemical, cosmetics and food industry. Today,...
